Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05861323 · ClinicalTrials.gov registry record · NA
Feasibility of the Comfort Measures Only Time Out (CMOT)
A NA study of Aging and Respiratory Failure, sponsored by Beth Israel Deaconess Medical Center.
- Active
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT05861323: Active NA study of Aging and Respiratory Failure, sponsored by Beth Israel Deaconess Medical Center.
NCT05861323 is a NA study of Aging and Respiratory Failure that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 184 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05861323, a NA study of Aging and Respiratory Failure, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
Nearly 25% of Americans die in intensive care units (ICUs). Most deaths in ICUs are expected and involve the removal of ventilator support, or palliative withdrawal of mechanical ventilation (WMV). Prior work by the Principal Investigator (PI) found that patient suffering can be common; with 30-59% of patients going through this process experiencing distress. Thus, experts and national organizations have called for evidence to inform guidelines for WMV. This research study will 1) develop and refine a Comfort Measures Only Time out (CMOT) intervention consisting of a structured time out with check-list protocol for the ICU team (nurse, physician, respiratory therapist) to improve the process of WMV. and 2) Pilot test the CMOT intervention in 4 ICUs (2 medical/2 surgical) among 40 WMV patients.
Primary Outcome
Recruitment rate will be determined by the number of eligible participants enrolled divided by the total number of eligible participants.
Conditions Studied
Interventions
- BEHAVIORAL Comfort Measures Only Time out (CMOT)
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT05861323 still lists
NCT05861323 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (92% lower).
The record links to 5 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Comfort Measures Only Time out (CMOT) is the first listed.
NCT05861323 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05861323 about?
NCT05861323 is a clinical study titled "Feasibility of the Comfort Measures Only Time Out (CMOT)". Nearly 25% of Americans die in intensive care units (ICUs). Most deaths in ICUs are expected and involve the removal of ventilator support, or palliative withdrawal of mechanical ventilation (WMV). Prior work by the Principal Investigator (PI) found that patient suffering can be common; with 30-59% ...
What is the current status of trial NCT05861323?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2023-10-20. Estimated completion is 2026-08-31.
What conditions does trial NCT05861323 study?
This clinical trial studies the following conditions: Aging, Respiratory Failure, End of Life, Coma, Ventilatory Failure.
What interventions are being tested in trial NCT05861323?
The interventions under investigation include: Comfort Measures Only Time out (CMOT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05861323?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05861323 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05861323's enrollment target sits among peer trials
184 55th of 262 higher than 208 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI